Inductive Bio

Developer of a machine learning platform designed to accelerate the compound optimization process. The company's platform specializes in building datasets and ML models to map the drivers of small molecule Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET), enabling scientists to optimize initial compounds into leads and development candidates faster and with a better balance of properties which helps them develop new therapeutics.

Lux Capital

Andreessen Horowitz

🏥 Healthcare